我们进行了一项荟萃分析,以分析慢性硬膜下血肿(CSDH)手术后的气颅对血肿复发的影响。死亡率,和功能结果。在这个荟萃分析中,遵循PRISMA准则,PubMed,Embase,科克伦图书馆,和WebofScience的在线数据库使用关键字“气颅,\"\"肺脑,颅内积气,\"\"肺炎脑,\"\"硬膜下空气,“和”慢性硬膜下血肿。“结果仅限于英语文章。通过在线数据库,我们共确定了276篇文章,最后纳入了14篇文章进行荟萃分析.结果显示,气颅组的复发率高于对照组,合并OR为3.35(CI:2.51-4.46,P<0.001)。无/少数和中度气颅组之间的复发率没有差异(OR:1.27,CI:0.68-2.37,P=0.46),但是大气颅组的复发率明显高于中度组,合并OR为3.29(CI:1.71-6.32,P<0.001)。这项研究未能显示出比对照组更高的死亡率和更差的结果。手术清除CSDH后的肺心病与血肿的复发率有关。影响复发的气肿与气体量相关,中度气颅可能影响较小,而与中度气颅相比,重度气颅患者更容易复发。需要更多的前瞻性队列研究进行进一步的调查和验证。这项荟萃分析已注册(PROSPEROCRD42022321800)。
We conducted a meta-analysis to analyze the effects of
pneumocephalus after chronic subdural hematoma (CSDH) surgery on hematoma recurrence, mortality, and functional outcomes. In this meta-analysis, following PRISMA guidelines, PubMed, Embase, Cochrane Library, and Web of Science online databases were queried using the keywords \"pneumocephalus,\" \"pneumoencephalos,\" \"intracranial pneumatocele,\" \"pneumo encephalon,\" \"subdural air,\" and \"chronic subdural hematoma.\" The results were limited to English-language articles. Through the online database, we identified a total of 276 articles and finally included 14 articles for meta-analysis. The results showed that the recurrence rate in the pneumocephalus group was higher than that in the control group, with a pooled OR of 3.35 (CI: 2.51-4.46, P < 0.001). There was no difference in recurrence rate between the no/few and moderate
pneumocephalus groups (OR: 1.27, CI: 0.68-2.37, P = 0.46), but the recurrence rate of the large pneumocephalus group was significantly higher than that of the moderate group, with a pooled OR of 3.29 (CI: 1.71-6.32, P < 0.001). This study failed to show higher mortality and worse outcomes in the
pneumocephalus group than in the control. Pneumocephalus after surgical evacuation of CSDH was associated with the recurrence rate of hematoma.
Pneumocephalus affecting recurrence was correlated with gas volume, and moderate
pneumocephalus may have less impact, while patients with large pneumocephalus are more likely to recur than those with moderate
pneumocephalus. More prospective cohort studies are needed for further investigation and verification. This meta-analysis was registered (PROSPERO CRD42022321800).